Vaccine Case–Population: A New Method for Vaccine Safety Surveillance

Hélène Théophile (), Nicholas Moore, Philip Robinson, Bernard Bégaud and Antoine Pariente
Additional contact information
Hélène Théophile: CHU Bordeaux
Nicholas Moore: CHU Bordeaux
Philip Robinson: CIC Bordeaux CIC1401
Bernard Bégaud: CHU Bordeaux
Antoine Pariente: CHU Bordeaux

Drug Safety, 2016, vol. 39, issue 12, No 6, 1197-1209

Abstract: Abstract Introduction The case–population approach compares exposure among cases to that of their source population. By using aggregated data to estimate the denominator, this approach can provide a real-time estimate of an association that could be particularly valuable to explore urgent vaccine safety concerns and to generate signals during a vaccine campaign. Objective Our objective was to present the vaccine case–population method, a method derived from the case–population approach and adapted for vaccine safety surveillance, and to test it using several published examples. Methods For the vaccine case–population method, exposure in the population is estimated from the sum of at-risk periods using the number of vaccinated individuals, or data of vaccine sales, and the at-risk period considered for the vaccine–event pair. The vaccine case–population method was applied to data from published case–control studies retrieved from the MEDLINE database and having quantified risks associated with vaccines. Odds ratios derived from the vaccine case–population method were compared with those from published case–control studies. Results A total of 20 vaccine–event pairs were retrieved in which the vaccine case–population method could be applied. For all identified vaccine–event pairs, when a significant association was found using the vaccine case–population method, a significant association was also found in the corresponding case–control study. Conversely, when no association was found by the vaccine case–population method, no association was found in the corresponding case–control study. Conclusion These results suggest that the vaccine case–population method can produce coherent conclusions and may be used in the future for prospective investigation of urgent vaccine safety concerns or for the prospective generation of vaccine safety signals. This method could also be used to identify selection bias from cases excluded from the case–control study.

Date: 2016
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-016-0449-2 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:39:y:2016:i:12:d:10.1007_s40264-016-0449-2

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-016-0449-2

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().